📰 Iagnostics News
Page 131 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
October 3, 2021
Diagnostics startup GRIP Molecular is developing an at-home test for Covid-19 and other respiratory infections. The technology builds on advances from several fields, including the discovery of graphene, a material that offers biocompatibility and conductivity.
October 2, 2021
Real-world data show T-Detect™ COVID can detect prior SARS-CoV-2 infection nearly 12 months after initial diagnosis in some patients New research...
October 1, 2021
With a change in people's sentiment and armed with tech advancements, the home-based diagnostics sector is likely to sail through smoothly. The recent great leaps in AI and IoT in healthcare, not to mention the need to maintain ‘social distancing’ and lack of workforce in the healthcare sector, as in others as well, has become a driving force to reckon with. Let’s explore this exciting new phase in healthcare.
October 1, 2021
STOCKHOLM, Oct. 1, 2021 /PRNewswire/ -- BICO Group AB (publ) ("BICO") has entered into an agreement with the shareholders of QInstruments GmbH ("QInstruments") to acquire all outstanding shares
October 1, 2021
Contract Pharmaceutical Fermentation Services Market Worth Observing Growth | Lonza, EKF Diagnostics, AbbVie
October 1, 2021
Contract Pharmaceutical Fermentation Services Market Worth Observing Growth | Lonza, EKF Diagnostics, AbbVie
September 30, 2021
SelectScience is a scientific publication for product news, application notes, events, videos and laboratory product reviews.
September 29, 2021
A bespoke nationwide facility for testing innovative nanotechnologies for healthcare applications is to be established at the University of Strathclyde.
September 22, 2021
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head and neck cancers (HNC), particularly oropharyngeal cancers (OPC, or throat cancers). Investigators have determined that HR-HPV DNA can be detected in saliva in most patients with HPV-driven OPC at the time of diagnosis. This work highlights a potentially life-saving screening program based on salivary HR-HPV DNA testing for early cancer detection and patient monitoring. Their...
September 22, 2021
Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.